Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  


Here is the latest stock price and chart of Glenmark Pharma. For more details, see the Glenmark Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Live BSE Quotes Mar 16, 2018 (Close)
Price (Rs)547.00 Open (Rs) 554.70 High (Rs) 560.00 Low (Rs) 544.65
% Change-0.58 Volume 16,409 Value (Rs) 9,065,247 52-Week H/L 930.00 / 517.40
Live NSE Quotes Mar 16, 2018 (Close)
Price (Rs)546.20 Open (Rs) 554.20 High (Rs) 560.90 Low (Rs) 544.00
% Change-1.37 Volume 809,649 Value (Rs) 446,329,991 52-Week H/L 915.90 / 517.05
EPS (Rs)* 43.75 P/E Ratio (x) 12.50 Market Cap (Rs m) 148,390.16 P/BV (x) 3.30
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Peer Group:
Quote & Graph
Advanced Charts new
Charts by TradingView

GLENMARK PHARMA Share Price Today:

GLENMARK PHARMA last traded price was down 0.6% to Rs 547.0 on the BSE. On the NSE, GLENMARK PHARMA last traded price was down 1.4% to Rs 546.2. The total volume of shares traded was 0.8 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 1.3%. And the benchmark S&P BSE SENSEX was at 33,176.0 (down 1.5%).

Over the last 30 days, the GLENMARK PHARMA share price is up 4.8%. And over the last one year, GLENMARK PHARMA share price is down 39.1%.

Today's Market

Sensex Plunges 500 Points; Metal & Energy Stocks Continue to Fall(Closing)

Indian share markets continued to witness further selling pressure in the afternoon session with financial and energy stocks taking the brunt as fears of a trade war.

Related Views On News

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Glenmark: Zetia Bolsters Sales and Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

The 180-day exclusivity for Zetia enabled Glenmark to show strong growth in sales and profits during the quarter.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

The Best Blue-Chip Stocks to Ride Sensex 100,000(The 5 Minute Wrapup)

Mar 8, 2018

Here are the four criteria by which you can easily identify safe blue-chip stocks to consider investing in this market correction if valuations fall to reasonable levels.

This Phone Call Changed How I Look at Markets...And Will Change You as Well(Smart Contrarian)

Mar 8, 2018

Nifty is down almost 10% from its all-time highs. It may be difficult for retail traders to make money in such markets but not for the institutional traders. Here's how they survive and thrive in such difficult times.

Is it Time to Redeem Your Balanced Fund(The Honest Truth)

Mar 5, 2018

Rs 50,000 crore of mis-selling and mis-understanding.

Trump's Trade Wars Aren't Going to Make America Great Again(Vivek Kaul's Diary)

Mar 12, 2018

The American president like other politicians is just looking at the first order effects of his decision to impose tariffs.

Mirae Asset Emerging Bluechip Fund: A Cautiously Managed Midcap Fund(Outside View)

Mar 6, 2018

PersonalFN takes deeper look at the performance of Mirae Asset Emerging Bluechip Fund.


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks